Dr. Lal Pathlabs Limited (LALPATHLAB.BO) Financials
LALPATHLAB.BO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 24.6 billion | 5.7 billion |
| 2023-12-31 | ? | ? |
| 2023-09-30 | 24.5 billion | 6.4 billion |
| 2023-06-30 | ? | ? |
LALPATHLAB.BO Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | 720.0 million | ? |
| 2023-09-30 | 718.0 million | ? |
| 2023-06-30 | 702.0 million | ? |
LALPATHLAB.BO Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 845.0 million |
| 2023-12-31 | 813.0 million |
| 2023-09-30 | 1.1 billion |
| 2023-06-30 | 826.0 million |
LALPATHLAB.BO Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 9.4 billion | - | 1.6 billion |
| 2023-12-31 | 9.0 billion | - | - |
| 2023-09-30 | 9.3 billion | 1.7 billion | 1.7 billion |
| 2023-06-30 | 8.2 billion | - | - |
LALPATHLAB.BO Shares Outstanding
LALPATHLAB.BO Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | - | 756.0 million | 352.0 million |
| 2023-12-31 | - | - | 777.0 million | 269.0 million |
| 2023-09-30 | 277.0 million | - | 852.0 million | 253.0 million |
| 2023-06-30 | - | - | 745.0 million | - |
LALPATHLAB.BO Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 5.5 billion | 3.3 billion |
| 2023-12-31 | 5.4 billion | 1.8 billion |
| 2023-09-30 | 6.0 billion | 2.1 billion |
| 2023-06-30 | 5.4 billion | 1.9 billion |
LALPATHLAB.BO
Price: ₹2,535.90
Dividend Yield: 1.08%
Forward Dividend Yield: 0.94%
Payout Ratio: 60.44%
Dividend Per Share: 24.00 INR
Earnings Per Share: 39.68 INR
P/E Ratio: 61.59
Exchange: BSE
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 209.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 9
DGR3: 17.66%
DGR5: 30.00%